OPK Q2 2024 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena

OPKOPKO Health, Inc.

$933M

Q2 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$182M-31.4% YoY

Gross Profit

$52M28.4% margin

Operating Income

-$62M-33.9% margin

Net Income

-$10M-5.7% margin

EPS (Diluted)

$-0.01

QoQ Revenue Growth

+4.9%

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$34M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$2.0B

Total Liabilities

$585M

Stockholders' Equity

$1.4B

Cash & Equivalents

$41M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$182M	$265M	-31.4%
Gross Profit	$52M	$126M	-59.2%
Operating Income	-$62M	$7M	-977.9%
Net Income	-$10M	-$20M	+47.5%

Revenue Segments

Service

$129M71%

Product

$40M22%

Transfer of Intellectual Property and Other

$12M7%

Geographic Segments

UNITED STATES

$142M78%

CHILE

$18M10%

IRELAND

$10M5%

MEXICO

$6M3%

SPAIN

$6M3%

Other Countries

$804,0000%

ISRAEL

$441,0000%